MYNZ
Mainz Biomed NV
NASDAQ · Healthcare · Medical - Diagnostics & Research · DE
$3.59
+0.84%Latest reported
- Last report date
- Sep 26, 2025
- EPS actual
- -$2.65
- EPS estimate
- —
- Revenue actual
- $286.7K
- Revenue estimate
- $497.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -824.8%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 26, 2025 | — | -$2.65 | — | $286.7K |
| Apr 8, 2025 | -$3.60 | -$9.60 | Miss -166.67% | $373.2K |
| Dec 26, 2024 | -$4.40 | -$16 | Miss -254.55% | $520.8K |
| Apr 9, 2024 | -$0.32 | -$9.60 | Miss -2900.00% | $214.8K |
| Nov 16, 2023 | -$20 | -$16 | Beat 22.00% | $500.2K |
| May 16, 2023 | -$19 | -$18 | Beat 4.26% | $251.4K |
| Nov 2, 2022 | -$0.43 | -$0.97 | Miss -125.90% | $278.5K |
| May 2, 2022 | — | -$1.30 | — | $160.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 26, 2025